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Summary
Dyskeratosis congenita is a rare inherited bone mar-
row–failure syndrome characterized by abnormal skin
pigmentation, nail dystrophy, and mucosal leukoplakia.
More than 80% of patients develop bone-marrow fail-
ure, and this is the major cause of premature death. The
X-linked form of the disease (MIM 305000) has been
shown to be caused by mutations in the DKC1 gene.
The gene encodes a 514-amino-acid protein, dyskerin,
that is homologous to Saccharomyces cerevisiae Cbf5p
and rat Nap57 proteins. By analogy to the homologues
in other species, dyskerin is predicted to be a nucleolar
protein with a role in both the biogenesis of ribosomes
and, in particular, the pseudouridylation of rRNA pre-
cursors. We have determined the genomic structure of
the DKC1 gene; it consists of 15 exons spanning a region
of 15 kb. This has enabled us to screen for mutations
in the genomic DNA, by using SSCP analysis. Mutations
were detected in 21 of 37 additional families with dy-
skeratosis congenita that were analyzed. These muta-
tions consisted of 11 different single-nucleotide substi-
tutions, which resulted in 10 missense mutations and 1
putative splicing mutation within an intron. The mis-
sense change A353V was observed in 10 different fam-
ilies and was shown to be a recurring de novo event.
Two polymorphisms were also detected, one of which
resulted in the insertion of an additional lysine in the
carboxy-terminal polylysine domain. It is apparent that
X-linked dyskeratosis congenita is predominantly
caused by missense mutations; the precise effect on the
function of dyskerin remains to be determined.
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Introduction
X-linked dyskeratosis congenita (DC) is a rare bone mar-
row–failure syndrome characterized by the early onset
of abnormal skin pigmentation, nail dystrophy, and mu-
cosal leukoplakia (Drachtman and Alter 1992; Dokal
1996). The X-linked form of the disease (MIM 305000)
is the most common, with 90% of patients being male,
although both autosomal recessive (MIM 224230) and
autosomal dominant (MIM 127550) forms are recog-
nized. Progressive bone-marrow failure develops in
140% of patients by age 10 years, increases to 180%
by age 30 years, and is the major cause of premature
death (Knight et al. 1998a). There is also an increased
incidence of a range of malignancies (Drachtman and
Alter 1992). Chromosomal instability is observed in the
fibroblasts and bone marrow of some patients (Pai et al.
1989; Kehrer et al. 1992; Dokal and Luzzatto 1994;
Demiroglu et al. 1997), although lymphocytes are not
sensitive to the clastogenic agents mitomycin C and die-
poxybutane, with respect to increases in chromosome
breakage (Coulthard et al. 1998). Carriers of the X-
linked form of the disease show a skewed X-chromo-
some inactivation pattern in peripheral-blood lympho-
cytes (Vulliamy et al. 1997; Devriendt et al. 1997; Fer-
raris et al. 1997). The candidate-gene region for the
X-linked form of the disease was originally mapped to
Xq28 (Connor et al. 1986) and was further refined to
a 1.4-Mb region in the distal end of Xq28 (Knight et
al. 1998b). The DKC1 gene was subsequently position-
ally cloned as the result of the identification of a partial
gene deletion in one male DC patient (Heiss et al. 1998).
Five additional mutations were subsequently detected in
the DKC1 cDNA of other patients (Heiss et al. 1998).
The partial gene deletion was shown to result in the loss
of the last exon of the gene, encoding the terminal 22
amino acids, but yields a viable transcript (Vulliamy et
al., in press).
The DKC1 gene encodes a 514-amino-acid protein,
dyskerin, that is highly conserved in evolution. Homol-
ogous proteins have been identified in other species, in-
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Table 1
Primers Used in SSCP Analysis
EXON
PRIMER DESIGNATION, SEQUENCE
ANNEALING
TEMPERATURE
(C)
SIZE OF PCR
FRAGMENT
(bp)Forward Reverse
1 ex1F, TCGGCTGTGGACCGGGCG ex1R, CGGGAACCAGAGGGAGGC 65 158
2 ex2F, AATCCATTTCCTACCTGCCC ex2R, CAAAGCTGGCCCATTCCTTG 63 276
3 ex3F, AAAGGCATACATTTCCATGG ex3R, CAAGGATGCCAGCAGTAAG 62 268
4 ex4F, GCCACATAGTGGTACTGACTC ex4R, CCTGAATAGCTGATGTGAAAG 60 242
5 ex5F, GATTTGTTGTTTCACTGGAGC ex5R, TTCACTCTAGCCAGTCCTTC 62 288
6 ex6F, GGAGTGACTGAGCATATAAG ex6R, AACCCATCTCCAGATGTTTAG 60 219
7 ex7F, GCTGCAGCCAGCCTGGACC ex7R, AGTCTTCAACTTCAAGGCATC 68 293
8 ex8F, GTGGCTCAGATGAAGGATAAC ex8R, GAGTGCCATCAAAGGCTGGC 62 284
9 ex9F, GGTCTGATGGGCTGAGATAC ex9R, GAGCAAGCGTCATCTTTGGAG 63 264
10 ex10F, CACTCCCTTGTTGTCCTCC ex10R, TATATACACCTAGTATGTAAC 60 272
11 ex11F, TAAAGTGGCATACAACAGTAG ex11R, ACCTGGCAGGGCACGCAAC 65 242
12 ex12F, ATTCTTTGTAGTCACCATGCC ex12R, AGCAAGTGTGCCGTCTCTACC 64 227
13 ex13F, CTACATAACATCAGTACTGCC ex13R, TAAGACGAATGCCAGTGCC 62 219
14 ex14F, TACCTTTTGACTCACTGAACC ex14R, GGTACCACCTGGGTAATTC 62 288
15 ex15F, GAACTTTGTGTCACATGCAGC ex15R, AACATGTTTTCTCAATAAGGC 58 278
cluding rat Nap57 (Meier and Blobel 1994), Sacchar-
omyces cerevisiae Cbf5p (Jiang et al. 1993), Drosophila
melanogaster Nop60B (Philips et al. 1998), and Kluy-
veromyces lactis Cbf5p (Winkler et al. 1998). Dyskerin
also has regions of homology with the class of bacterial
Trub proteins (Nurse et al. 1995) and the S. cerevisiae
PUS4 protein (Becker et al. 1997). By analogy to the
predicted functions of the orthologues in other species,
dyskerin is likely to be a multifunctional nucleolar pro-
tein involved in centromere function (Jiang et al. 1993,
1995), nucleocytoplasmic trafficking (Meier and Blobel
1992, 1994), rRNA transcription (Cadwell et al. 1997),
the stability of H  ACA snoRNA particles (Lafontaine
et al. 1998), ribosome biosynthesis (Cadwell et al. 1997;
Lafontaine et al. 1998; Luzzatto and Karadimitris 1998),
and RNA pseudouridylation (Lafontaine et al. 1998).
We have now determined the genomic structure of the
DKC1 gene, which has allowed for the development of
an SSCP mutation-screening strategy in male DC
patients.
Patients and Methods
Patients
DNA samples from 37 families with DC were ana-
lyzed; 14 of these families were multiplex families, with
two or more affected males, and the remaining 23 were
sporadic families, with a single affected male patient. Of
the 37 families, 36 were recruited from the Dyskeratosis
Congenita Registry, and the other family, pedigree
NIGMS 515, was from the Coriell Cell Repository. In
family DCR-046, a sample from the proband was not
available, so the mother of the proband was used in the
screening. Ethical approval was obtained from the local
medical ethical committee, for the use of patient samples
in this study.
Determination of the Genomic Structure of the DKC1
Gene
The genomic structure of the DKC1 gene was deter-
mined by the sequencing of subcloned fragments from
cosmid Qc11G6 and genomic PCR fragments. PCR was
performed with an initial denaturation of 94C for 2
min, then 35 cycles each of 96C for 30 s, 60C for 30
s, and 72C for 3 min, followed by 72C for 10 min.
Intronic fragments were gel purified, TA-cloned (pGEM-
TEasy; Promega), and sequenced. Sequences were edited
and assembled by the GAP4 program (Staden). For ac-
curacy, most sections of the gene were sequenced from
at least two independent clones, and a minimum three-
fold sequence redundancy was ensured.
SSCP Analysis
Each of the exons was screened for sequence changes
in every patient. Primers flanking each exon were de-
signed; the primer sequences, the corresponding sizes of
fragments, and the PCR annealing temperatures are
given in table 1. A [32P]-labeled fragment corresponding
to each exon was generated by a 20-ml PCR reaction
performed in the presence of 1 mM of each primer pair,
together with 0.01 ml of [32P]-dCTP. To 3.5 ml of the
PCR reaction, 2 ml of formamide loading buffer (100%
formamide, 1 mM EDTA, 1 mg of bromophenol blue/
ml, and 1 mg of xylene cyanol/ml) was added. Each
sample was heat-denatured, placed on ice, and then
loaded onto a nondenaturing polyacrylamide gel by a
vertical electrophoresis apparatus (S2; Gibco-BRL). Two
sets of running conditions were used: (1) a 6% acrylam-
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Table 2
DKC1 Mutations in Families with DC
Family Ethnic Origin Family History Exon DNA Change Protein Change Restriction Enzyme Inheritance
DCR-004 United Kingdom Sporadic 11 1058CrT A353V MspAI () Inherited
DCR-005 United Kingdom Multiplex 11 1058CrT A353V MspAI () Inherited
DCR-006 Italy Multiplex 11 1058CrT A353V MspAI () Inherited
DCR-008 United Kingdom Sporadic 3 115ArG K39E TaqI () De novo in mother
DCR-009 Italy Multiplex 10 961CrG L321V MboII () De novo in grandparents
NIMGS 515 United States Multiplex 4 196ArG T66A No sample available Unknown
DCR-020 France Sporadic 11 1058CrT A353V MspAI () De novo in proband
DCR-021 Austria Sporadic 11 1050GrA M350I No sample available Unknown
DCR-027 India Multiplex 12 1204GrA G402R NlaIII () Unknown
DCR-029 United States Sporadic 11 1058CrT A353V MspAI () De novo in proband
DCR-030 United Kingdom Multiplex 11 1058CrT A353V MspAI () Inherited
DCR-031 United Kingdom Sporadic 11 1049TrC M350T AseI () Inherited
DCR-033 Germany Multiplex 4 194GrC R65T MaeIII () Inherited
DCR-038 Turkey Sporadic 3 121GrA E41K HinfI () Inherited
DCR-041 United Arab Emirates Multiplex 1 5CrT A2V AciI () Unknown
DCR-044 United States Sporadic 11 1058CrT A353V MspAI () De novo in proband
DCR-046 United Kingdom Sporadic 11 1058CrT A353V MspAI () De novo in grandparents
DCR-050 Spain Sporadic IVS2 5CrG ) TaqI () Inherited
DCR-051 United States Multiplex 11 1058CrT A353V MspAI () Inherited
DCR-055 Spain Multiplex 11 1058CrT A353V MspAI () De novo in proband
DCR-056 United States Sporadic 11 1058CrT A353V MspAI () De novo in proband
ide (99:1 acrylamide:bis-acrylamide), , 10%1# TBE
glycerol gel run for 15–19 h at 15 mA at room tem-
perature; and (2) a 4% acrylamide (37:1 acrylamide:bis-
acrylamide), , 10% glycerol gel run for 17-191# TBE
h at 15 mA at 4C. The gels were then dried and exposed
to x-ray film for 6–24 h. Any patient sample that showed
a shift on the SSCP gel was then reamplified in the ab-
sence of [32P]-dCTP, and the PCR fragment was purified
by use of a Qiagen column. The samples were then se-
quenced on an ABI 373 automatic sequencer. The lo-
cations of the sequence changes were numbered with
respect to the DKC1 cDNA sequence (AJ224481), with
the A of the ATG numbered as “1.”
Segregation Analysis and Polymorphism Screening
Confirmation of any sequence changes detected was
performed by the appropriate restriction-enzyme diges-
tion, when available (table 2). For those pedigrees in
which additional family members were available, it was
possible to investigate the segregation of any mutation
with the disease by the use of the appropriate restriction
digestion. To investigate the possibility that any sequence
change represented a polymorphism, 50 normal U.K.
white women were screened; this was not done for those
sequence changes shown to be de novo sequence
changes. The recurrent A353V change was investigated
by amplification using primers ex11F and ex11R, fol-
lowed by a MspA1I digestion; the substitution C to T
at position 1058 results in the loss of a MspA1I restric-
tion site. The polymorphism screening for the other se-
quence changes, in exons 1, 3, 4 , 11, and 12, was per-
formed by SSCP as described above. In the case of the
insertion polymorphism in exon 15, a set of individuals
of either Greek or Turkish origin were also analyzed.
The polymorphic substitution GrA in the 3′ UTR at
position 1551 was investigated by amplification with
primers ex15F and ex15R, followed by HaeIII digestion.
The presence of an additional AAG codon in exon 15
was investigated by [32P]-labeled amplification using
primers ex15F and ex15R, followed by analysis of the
samples on a denaturing 6% polyacrylamide-urea gel.
The Xq28 haplotype analysis was performed by use of
polymorphic markers DXS52 and sKK5, as described
elsewhere (Richards et al. 1991; Knight et al. 1998b).
Results
Genomic Structure of the DKC1 Gene
The DKC1 gene consists of 15 exons spanning almost
to 15 kb (fig. 1). The size range of the internal exons is
65–185 bp. The first exon consists of a 92-bp 5′ UTR
and 16 bp of coding region; the last exon is 908 bp long
and comprises a 839-bp 3′ UTR (table 3 and fig. 1).
Overall, the introns are small (size range 194–2251 bp)
(table 3). A sequence gap of 600 bp remains in intron
11, and the size of this intron was estimated on the basis
of the PCR product. The sequences of the splice junc-
tions are given in table 3. The GenBank accession num-
bers for the entire genomic sequence are AJ0101395
(exons 1–11) and AJ0101396 (exons 12–15). By in-
spection, all of the 5′ splice-donor sites and 13 of the 14
splice-acceptor sites conform to the known consensus
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Figure 1 Schematic representation of gene structure of DKC1. The coding exons are represented by gray-shaded boxes, numbered
“1”–“15,” and the 5′ and 3′ UTRs are represented as unshaded boxes. The gap in intron 11 is indicated by a partially dashed line. The direction
of the repetitive elements with respect to the gene are shown by the unblackened arrows; A  Alu, M  MER, L LINE, and SR  SINE-
R11. The locations of the NLSs, Trub domains, the hydrophobic repeat, and the lysine-rich domain are indicated. The gene is transcribed in
a telomere-to-centromere direction.
sequence (table 3) (Mount 1982). The one exception was
the 3′ splice-site acceptor for intron 2; in this case there
is the rare occurrence of an adenine at the 3 position
(table 3) (Mount 1982). The following repetitive ele-
ments were identified by RepeatMasker 2 (Repeat-
Masker documentation): two medium-reiteration-fre-
quency repeats (MERs), six Alu elements, and the 3′
UTRs of three long interspersed repetitive elements
(LINEs) (see fig. 1). The simple repeat sequence
(TA)6AATA(TG)4(TA)3TG(TA)2T(TA)3(TGTA)2T(TA)2-
(TGTA)2TAT(TA)6 was found in intron 1.
A 643-bp segment in intron 11 of the DKC1 gene
showed homology to the short interspersed repeat
(SINE)–type family of nonviral retroposons, called
“SINE-R” (fig. 1) (Ono et al. 1987; Zhu et al. 1992).
The DKC1 retroposon shows highest identity to SINE-
R11 (95%). SINE-R retroposons have a 5′r3′ direction,
and the DKC1 SINE-R element lies in an orientation the
reverse of that of the DKC1 gene. It consists of a GC-
rich stretch of 40-bp tandem repeats followed by a po-
lypurine tract, a glucocorticoid-responsive element, a
poly(A) signal, and a poly(A) tail. This is characteristic
of SINE-R elements, which are derived largely from the
human endogenous retrovirus HERV-K10 long terminal
repeats (Zhu et al. 1992). In intron 11 of DKC1 a 21-
bp direct repeat sequence (CCAGCATTGACACCA-
TTCTAA) flanks the GC-rich stretch and the boundaries
of the sequence gap. This may explain why it was not
possible to sequence this section of the gene.
SSCP Screening of the DKC1 Gene in Patients with
DC
Primers were designed from the genomic sequence of
the DKC1 gene such that each exon could be amplified
and screened, by SSCP, for sequence changes (table 1).
Every sample from patients was screened, in each exon,
with two different sets of SSCP conditions. Mutations
were detected in 21 of the 37 families analyzed. All of
these were single-nucleotide substitutions and comprised
10 different missense coding changes and 1 change
within an intron. For those mutations that were not de
novo, 50 normal white U.K. women were screened to
exclude polymorphisms; in each case, none of the normal
women carried these sequence changes (data not shown).
The nucleotide substitution CrT at position 1058 in
exon 11, resulting in the missense mutation A353V, was
detected in 11 different families (DCR-004, DCR-005,
DCR-006, DCR-021, DCR-030, DCR-031, DCR-044,
DCR-046, DCR-051, DCR-055, and DCR-056) (table
3). These pedigrees were from disparate geographical
locations. This change was shown to be a de novo event
in the probands in families DCR-020, DCR-029, DCR-
044, DCR-055, and DCR-056 (fig. 2). In addition, this
change was also shown to be de novo in the mother of
the proband in family DCR-046. Also in exon 11, two
different nucleotide substitutions affecting the same co-
don were detected: nucleotide 1049TrC (M350T) in
pedigree DCR-031 and nucleotide 1050GrA (M350I)
in pedigree DCR-021. A maternal sample was available
only from pedigree DCR-031, and in this case the mu-
tation was shown to have been inherited from the
mother. Three different single-nucleotide substitutions
were detected by primers spanning exon 3, which re-
sulted in the missense mutations K39E in family DCR-
008, E41K in family DCR-038, and a CrG substitution
at position 5 of intron 2 in family DCR-050 (table 2).
The mutations in families DCR-008, DCR-038, and
DCR-050 were each shown to have been maternally in-
herited. Two different missense mutations were detected
in exon 4; these were single-nucleotide substitutions re-
sulting in amino changes R65T (in family DCR-033) and
T66A (in family NIGMS-515). Two further single-nu-
cleotide substitutions leading to missense mutations
were observed: L321V in exon 10 (family DCR-009)
and G402A in exon 12 (family DCR-027). In family
DCR-009 (fig. 3), the mutation was detected in the pro-
band’s mother (II-8) and in one of his aunts (II-1) but
was not observed in either of the grandparents (I-1 and
I-2), which suggested that it was a de novo event. Hap-
lotype analysis using the markers DXS52 and sKK5 in-
dicated that the proband’s X chromosome had been in-
herited from the maternal grandfather, and it also
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Figure 2 Illustration of recurrent de novo A353V mutation.
DNA from the proband and the mother was amplified in sporadic
families DCR-029, DCR-044, and DCR-056 and then was digested
with MspA1I. The presence of the mutation results in the loss of the
restriction site. The size of molecular-weight makers is given.
Table 3
Sequence of Splice-Acceptor and Splice-Donor Sites of the DKC1 Gene
Splice-Acceptor Sequence Exon
Exon Size
(bp) Splice-Donor Sequence
Intron Size
(bp)
1 108 ATGGCGGATGCGGAAG/gtaagggctgcaggct 1,915
gtgtttgtttttttag/TAATTATTTTGCCAAA 2 68 AGAAGAAGATGTAGCC/gtgagtagtaatgtgt 477
ttctgtcctgtcgaag/GAAATACAACACGCTG 3 87 GCCCCTTTTGCTAAAG/gtatgtggttaaaatc 376
tgtcgttgctttgtag/AATTTTGATAAGCTGA 4 92 TTGGGGACTATATCAG/gtaagtgttgggagga 217
tttttttccattccag/GACAGGTTTCATTAAT 5 185 TCACAACAGAGTGCAG/gtatgtgggagaggga 596
ttttgtcatttttcag/GCAAAGAGTATGTGGG 6 65 GACCCAGCTTTCTAGG/gtaagtctgcaattgt 194
ttgtgtttgttcttag/GCCCTAGAAACTCTGA 7 127 CCTGAAAGAAGATTAG/gtgagtcattaggcct 917
tgtgtgtgtatcttag/GAATCTTTTGGGTGAG 8 131 AGTCATGAGTGAAAAG/gtatgtgttacggggc 733
catggctgcttttcag/GACCACATGGTGACAA 9 144 TATGAAAGACAGTGCA/gtaagttccgggttag 1,446
ggtgccatctctgcag/GTAAATGCCATCTGCT 10 121 GAAGCAATCTGCATGG/gtaagaggggatgttt 2,251
tattcaatgcctgtag/CTATTGCATTAATGAC 11 119 GGGTTTAGGCCCAAAG/gtaagtggtactgggt 1,350
cttgatgttccaccag/GCAAGTCAGAAGAAGC 12 104 AGTATGTTGACTACAG/gtgagggcaggatgtt 489
gctacctctttttcag/TGAGTCTGCCAAAAAA 13 79 AGCAAAAACTGCGAAG/gtgagtggcatgctgt 913
attgctttcatctcag/CGGAAGCGAGAGAGTG 14 138 CGAGCCTGGAGATGGG/gtgtgtggaaacacgt 474
ttctctttctttctag/GACAGTGATACCACCA 15 908
confirmed that a cousin of the proband (III-3) shared
the haplotype with the proband (III-5) but did not have
the L321V mutation (fig. 3). Considered together, these
observations suggest that the maternal grandfather was
a germline mosaic for the mutation.
Polymorphisms in the DKC1 Gene
A nucleotide substitution, GrA at position 1551 in
exon 15, located 6 nucleotides downstream from the
TAG stop codon in the 3′ UTR, was observed in three
families with DC. This sequence change was shown to
be polymorphic, with a frequency of 11/100 for the
1551A allele when a normal white U.K. population was
screened. In family DCR-008, the 1551A allele, resulting
in the loss of a HaeIII restriction site, was observed, in
cis, with the missense coding change K39E, in the pro-
band. The combination of the DXS52 haplotype and the
DKC1 mutation analysis in this family confirmed that
an unaffected cousin of the proband had inherited the
same DXS52 allele and the 1551A allele without the
K39E. These data confirm that the 1551A was not dis-
ease causing and that the K39E mutation was a de novo
event.
A second polymorphism was due to an insertion of
an additional AAG triplet in a stretch of seven AAGs
within exon 15 (nucleotides 1494–1514). This poly-
morphism was observed, in cis, with the coding change
E41K, in family DCR-038 from Turkey. The (AAG)8
allele was not observed in 100 normal X chromosomes
from a white U.K. population. However, the (AAG)8
allele was observed in 3 of 53 X chromosomes from
individuals of Greek origin and in 3 of 29 X chromo-
somes from individuals of Turkish origin, including a
hemizygote normal male (data not shown).
Discussion
The DKC1 gene consists of 15 exons spanning a 15-
kb region (fig. 1) and is located 1 kb from the MPP1
gene, in a tail-to-tail configuration (Vulliamy et al., in
press). The identification of the genomic structure of the
DKC1 gene has facilitated the screening of 37 male pa-
tients with DC for mutations. SSCP analysis identified
DKC1 mutations in 21 of these 37 patients. A total of
11 different single-nucleotide substitutions were de-
tected, which represented 10 missense coding mutations
and 1 intron mutation (table 2). The failure to detect
mutations in the other patients may be due to either
inefficiency of the SSCP analysis or the fact that some
of these other patients have DKC1 mutations outside
the coding and splice-site regions that were the subject
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Figure 3 Haplotype and mutation segregation in family DCR-
009, showing segregation of the L321V mutation, which mutation
results in the loss () of a MboII site in exon 10. A haplotype of the
markers DXS52 and sKK5 is also indicated.
of this study. Of the 16 patients in whom DKC1 mu-
tations were not identified by SSCP, 13 were male spo-
radic cases. It is possible that some of the male sporadic
cases have the autosomal form of the disease. Evidence
for the putative autosomal DKC2 gene comes both from
reports of women who have the identical phenotype (see
review by Drachtman and Alter [1992]) and case reports
of male-to-male transmission of DC (Gasparini et al.
1985).
One particular mutation, A353V (1058CrT), was de-
tected in 11 families (table 3). This was the only mu-
tation identified in those families in which it was found;
and, as well, a screen of 100 normal X chromosomes
failed to detect A353V as a polymorphism. In terms of
its geographical distribution, there was no evidence for
a founder effect, and, in fact, it was shown to be a de
novo event in six of the families; however, it is possible
that some of the other five families with DC and the
A353V mutation share a common ancestor. This mu-
tation represents an example of a CpGrTpG change that
is known to occur at a high frequency as the result of
the deamination of the methylated cytosine. The A353V
mutation was detected in 30% (11/37) of the male pa-
tients with DC who were analyzed in this study; this
represents 26% (11/43) of all male patients with DC
who have been analyzed so far (Heiss et al. 1998). The
occurrence of a common A353V mutation has a signif-
icant diagnostic consequence for the future screening for
DKC1 mutations in other patients with DC.
In this study, the one sequence change detected that
was not a missense coding mutation was a CrG sub-
stitution at position 5 in intron 2 in family DCR-050.
It is interesting to note that the splice-acceptor site in
intron 2 has an adenine at position 3 (table 3); this is
unusual, since purine nucleotides at this position have
been observed in only 5% of splice acceptors (Mount
1982). This sequence change was not found in 50 white
U.K. women, although the possibility remains that it
represents a rare polymorphism in Spain, whence this
family originated. An RNA sample was not available
from the proband in pedigree DCR-050; therefore, the
precise affect that this sequence change has on splicing
could not be determined. The CrG change at position
5 does change a pyrimidine to a purine in the consen-
sual polypyrimidine track. Such polypyrimidine-track
mutations have been described in the b-globin gene
(Beldjord et al. 1998; Murru et al. 1991), the ATR-X
gene (Villard et al. 1996), and the steroidogenic acute-
regulatory-protein gene (Tee et al. 1995).
Two polymorphisms were observed in the DKC1 gene;
one was an ArG at position 1551 within the 3′ UTR,
and the other was the presence of an additional AAG
triplet within exon 15. The AAG insertion was not ob-
served in a white U.K. populations but was shown to
be polymorphic in people of Greek origin and in people
of Turkish origin. The AAG insertion results in the pres-
ence of an additional lysine in a stretch of eight lysines
encoded by (AAG)7 AAA (amino acids 498–505), which
implies that the precise number of lysines in this region
is not essential for the normal function of dyskerin. It
is possible that this insertion is the result of a triplet-
expansion mechanism similar to that which results in
the expansions of the identical triplet within intron 1 of
the FRDA gene (Campuzano et al. 1996).
The mutations detected in this study, together with
the four missense mutations, one single-amino-acid de-
letion, and one carboxy-terminal deletion identified in
previous studies (Heiss et al. 1998) imply that X-linked
DC is predominantly caused by missense dyskerin mu-
tations: of the 17 known mutations of dyskerin, 14 are
missense changes (fig. 4). It remains a possibility that
additional mutations affecting splicing and level of ex-
pression will be detected in other patients with DC. To
date, no premature terminations, frameshifts, or com-
plete deletions have been identified in the DKC1 gene,
and it can be speculated that such large-scale loss of
dyskerin activity would be lethal to the cells. All the
missense mutations so far identified are nonconservative
changes (fig. 4). It is interesting to note that two pairs
of mutations affect the same codons: (1) M350T and
M350I and (2) G402E and G402R. The changes cluster
in two regions: 7 of 14 missense mutations are in exons
3 and 4 (amino acids 36–72), and 3 of 14 mutations,
including the recurrent mutation, are in exon 11 (amino
acids 350–353) (fig. 4). The precise function(s) of dy-
skerin remains to be determined, and therefore the effect
of each of the mutations cannot be accurately assessed.
The very high level of amino acid–sequence identity
between the S. cerevisiae Cbf5p protein and dyskerin
(Heiss et al. 1998) suggests that these proteins are func-
tional orthologues and that, therefore, analysis of the
yeast protein is extremely pertinent to an understanding
of the function of dyskerin. Except for A2V and A353V,
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Figure 4 CLUSTAL alignment of dyskerin and Cbf5p, showing
locations of all coding mutations. Mutations affecting single amino
acids are represented as white letters in black boxes, and the corre-
sponding amino acid changes are shown above the alignment. Previ-
ously identified single amino acid mutations are underlined (Heiss et
al. 1998). The location of the carboxy-terminal deletion is indicated
by a horizontal line (Vulliamy et al., in press). The exon boundaries
are demarcated by vertical arrows. NLSs are indicated by dashed
boxes, the two Trub domains are gray shaded, and amino acids form-
ing the hydrophobic repeat domain are marked by open boxes. Stars
indicate amino acids that are identical between dyskerin and Cbf5p;
dots indicate different but conserved amino acids.
all the amino acid changes observed in patients with DC
occur at positions that are conserved with respect to the
Cbf5p protein (fig. 4). In the case of the recurrent A353V
mutation, Cbf5p has a valine at the homologous position
(fig. 4). In view of the fact that dyskerin and Cbf5p are
so similar, it is surprising that a mutation that makes
dyskerin more similar to Cbf5p would have a deleterious
effect on its activity and cause the disease. None of the
missense mutations alter the sequence of any of the pu-
tative phosphorylation sites or nuclear-localization sig-
nals (NLSs) (fig. 4). In addition, all of the missense mu-
tations are located outside the bipartite Trub motif
(amino acids 91–104 and 121–134), which has been
shown to be conserved in other pseudouridine synthases
and is thought to represent the active site of the enzyme
(Koonin 1996) (fig. 4). In the case of the A2V change,
the reason that it is pathogenic is not obvious.
The fact that DC is caused predominantly by missense
mutations within a restricted number of regions of the
protein raises the possibility that mutations affecting dif-
ferent regions of dyskerin may produce different disease
phenotypes. For this reason, the DKC1 gene may be seen
as a potential candidate for other syndromes that map
to Xq28 and that have some phenotypic overlap with
DC—for example, incontinentia pigmenti (IP2 [MIM
308310]) (Smahi et al. 1994; Jouet et al. 1997). In ad-
dition, DKC1 mutations may account for some of the
male patients who develop idiopathic aplastic anemia,
particularly those presenting at a very young age. It is
hoped that a better molecular understanding of the un-
derlying cause of DC will enable the development of
therapeutic strategies and also provide insights into the
mechanism of aplastic anemia in general.
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